Hjem › Pankreaskreft › District of Columbia
Kliniske studier for Pankreaskreft i District of Columbia
11 studier for Pankreaskreft søker deltakere på steder i District of Columbia.
Byer i District of Columbia
Offisiell studietekst (engelsk)
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06423326A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Washington D.C.
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07127874A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07277413A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
- Georgetown University Medical Center, Washington D.C.
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06989437A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Investigative Site US013, Washington D.C.
- Investigative Site US046, Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07522073Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- MedStar Georgetown University Hospital, Washington D.C.
RekruttererObservasjonsstudie
Alder 50 til 75 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT04239573Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- Sibley Memorial Hospital, Washington D.C.
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT04172532Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- MedStar Washington Hospital Center, Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT06958328A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Washington D.C.
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. feb. 2026 · NCT06906562LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- MedStar Georgetown University Hospital, Washington D.C.
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 9. jan. 2026 · NCT06073431VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- The George Washington University Cancer Center (site 212), Washington D.C.
RekruttererFase 1/2
Alder 18 til 80 · Alle kjønn · Oppdatert 11. des. 2025 · NCT03556228Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.